Innoviva
INVA
114 hedge funds and large institutions have $1.37B invested in Innoviva in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 34 reducing their positions, and 25 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 120 → 114 (-6)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
16% less capital invested
Capital invested by funds: $1.63B → $1.37B (-$262M)
52% less call options, than puts
Call options by funds: $4.12M | Put options by funds: $8.62M
Top Buyers
Top Sellers
INVA Hedge Fund Activity: Q4 2014 in Review
114 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2014, worth a combined $1.37B — down 16% from $1.63B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of INVA and 21 opened new positions — a net loss of 4 holders — while 34 trimmed existing stakes and 43 added.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $40.4M. The largest seller was Capital World Investors, cutting an estimated $43.9M.
- 114 institutional investors held Innoviva (INVA) as of Q4 2014, down from 120 in Q3 2014.
- Funds reported $1.37B of Innoviva stock for Q4 2014, down 16% quarter-over-quarter.
- 21 funds opened new Innoviva positions in Q4 2014 and 25 closed out, a net change of -4 holders.
- The largest Innoviva buyer in Q4 2014 was Manulife (Manufacturers Life Insurance), an estimated $40.4M added.
- The largest Innoviva seller in Q4 2014 was Capital World Investors, an estimated $43.9M sold.
Based on aggregated 13F filings for Q4 2014.